About

Novoic leverages advanced AI models in its software for the crucial early detection of cognitive impairments like Alzheimer's through speech-based testing. The company's commitment to ensuring data integrity and its use of automated assessments to predict amyloid PET positivity provide a robust platform for professionals in neurology and AI research. The innovative approach in health technology not only offers a challenging environment for growth but also provides a direct impact on improving patient outcomes in the medical field.